Universitas Padjadjaran
🇮🇩Indonesia
- Country
- 🇮🇩Indonesia
- Ownership
- Private
- Established
- 1957-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.unpad.ac.id
High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study
Phase 2
Completed
- Conditions
- Tuberculosis, Meningeal
- Interventions
- First Posted Date
- 2014-06-23
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- Universitas Padjadjaran
- Target Recruit Count
- 60
- Registration Number
- NCT02169882
- Locations
- 🇮🇩
Hasan Sadikin General Hospital, Bandung, Jawa Barat, Indonesia
Pulmonary Tuberculosis Patients With Diabetes Mellitus
Not Applicable
Completed
- Conditions
- Diabetes MellitusPulmonary Tuberculosis
- Interventions
- Procedure: intensive monitoring
- First Posted Date
- 2014-04-07
- Last Posted Date
- 2019-04-18
- Lead Sponsor
- Universitas Padjadjaran
- Target Recruit Count
- 350
- Registration Number
- NCT02106039
- Locations
- 🇮🇩
Faculty of Medicine, Universitas Padjadjaran, Bandung, West Java, Indonesia
🇵🇪Universidad Peruana Cayetano Heredia, Lima, San Martin De Porres, Peru
🇷🇴University of Medicine and Pharmacy Craiova, Bucharest, Romania
Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation
Phase 2
Completed
- Conditions
- Tuberculous Meningitis
- Interventions
- First Posted Date
- 2013-03-01
- Last Posted Date
- 2014-06-17
- Lead Sponsor
- Universitas Padjadjaran
- Target Recruit Count
- 30
- Registration Number
- NCT01802502
- Locations
- 🇮🇩
Hasan Sadikin Hospital, Bandung, West Java, Indonesia
Effect of Exogenous Lactate on Neurocognitive in Brain Trauma
Not Applicable
Completed
- Conditions
- Traumatic Brain Injury
- Interventions
- Drug: hyperosmolar sodium lactate
- First Posted Date
- 2011-10-19
- Last Posted Date
- 2011-10-21
- Lead Sponsor
- Universitas Padjadjaran
- Target Recruit Count
- 60
- Registration Number
- NCT01455376
- Locations
- 🇮🇩
Hasan Sadikin Hospital, Bandung, West Java, Indonesia
Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study
Phase 2
Completed
- Conditions
- Meningitis, TuberculousPharmacokineticsPharmacodynamicsTolerability
- Interventions
- First Posted Date
- 2010-07-08
- Last Posted Date
- 2012-06-07
- Lead Sponsor
- Universitas Padjadjaran
- Target Recruit Count
- 60
- Registration Number
- NCT01158755
- Locations
- 🇮🇩
Hasan Sadikin General Hospital, Bandung, West Java, Indonesia
© Copyright 2025. All Rights Reserved by MedPath